<label id="mboud"><meter id="mboud"></meter></label>

        <rt id="mboud"><small id="mboud"><strike id="mboud"></strike></small></rt>
        咨詢熱線

        15000266580

        當前位置:首頁 >產品中心>細胞庫>人腫瘤細胞、癌細胞>CRL-2557Panc 05.04 人胰腺癌細胞

        Panc 05.04 人胰腺癌細胞

        簡要描述:CRL-2557 Panc 05.04 人胰腺癌細胞,
        原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,
        提供的細胞株背景清楚,提供參考文獻和培養條件!

        • 產品型號:CRL-2557
        • 廠商性質:生產廠家
        • 更新時間:2025-07-19
        • 訪  問  量:2126

        產品分類

        Product Category

        詳細介紹

        CRL-2557 Panc 05.04 人胰腺癌細胞

        ATCC® Number: CRL-2557™ Price: $417.00

        Designations: Panc 05.04

        Depositors: EM Jaffee

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: adherent

        Organism: Homo sapiens (human)

        Morphology: epithelial

        Source: Organ: pancreas

        Disease: adenocarcinoma

        Cellular Products: cytokeratins 7 and 18 [50655]

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2557 Panc 05.04 人胰腺癌細胞

        Isolation: Isolation date: May 5, 1995

        Tumorigenic: Yes

        Oncogene: K-ras +

        Antigen Expression: MHC class I +; MHC class II - [50655]

        Blood type B; Rh+

        Age: 77 years adult

        Gender: female

        Ethnicity: White

        Comments: Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.

        The cell line exhibits a K-ras oncogene mutation at codon 12 where a GGT --> GAT mutation resulted in substitution of aspartic acid for glycine. [50655]

        The cells have a reported plating efficiency of 100%. [50655]

        Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 20 Units/ml human recombinant insulin, 85%; fetal bovine serum, 15%

        Atmosphere: air, 95%; carbon dioxide (CO2), 5%

        Temperature: 37.0°C

        Subculturing: Protocol:

        1.Remove and discard culture medium.

        2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.

        3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

        Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

        4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

        5.To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximay 125 xg for 5 to 10 minutes.Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels.

        6.Incubate cultures at 37°C.

        Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:5 is recommended

        Medium Renewal: Add media once per week. Fluid change one to two times per week.

        Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

        Storage temperature: liquid nitrogen vapor phase

        Doubling Time: 46 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602

        CRL-2557


















        產品咨詢

        留言框

        • 產品:

        • 您的單位:

        • 您的姓名:

        • 聯系電話:

        • 常用郵箱:

        • 省份:

        • 詳細地址:

        • 補充說明:

        • 驗證碼:

          請輸入計算結果(填寫阿拉伯數字),如:三加四=7
        聯系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區四平路710號7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
        技術支持:化工儀器網    管理登陸
        主站蜘蛛池模板: 亚洲一线产品二线产品| 亚洲AV无码乱码在线观看性色扶| 成人黄网站片免费视频| 污污网站免费观看| 动漫黄网站免费永久在线观看| 国产一卡2卡3卡4卡2021免费观看| 成人永久福利免费观看| tom影院亚洲国产一区二区| 免费在线观看a级毛片| 亚洲熟妇无码一区二区三区导航| 国产精品久久久久久久久久免费| 亚洲一区二区三区久久| 永久免费av无码不卡在线观看| 亚洲中文字幕无码久久2020| 全免费一级毛片在线播放| 在线91精品亚洲网站精品成人| 麻豆国产入口在线观看免费| 免费一级全黄少妇性色生活片| 亚洲精品无码成人片在线观看| 今天免费中文字幕视频| 久久久亚洲欧洲日产国码是AV | 国产精品免费一区二区三区| MM131亚洲国产美女久久| 激情综合亚洲色婷婷五月APP| 最近中文字幕mv免费高清电影| 国产精品亚洲综合网站| 亚洲人成亚洲人成在线观看 | 亚洲国产精品特色大片观看完整版| 亚洲色少妇熟女11p| 四虎影视在线永久免费观看| 久久久久久国产a免费观看不卡 | 亚洲精品动漫人成3d在线| a级毛片毛片免费观看久潮| 亚洲精品中文字幕无乱码| 久久国产精品免费看| 亚洲中文字幕无码日韩| 国产人成网在线播放VA免费| 久久久久亚洲AV成人片| 天天操夜夜操免费视频| 亚洲欧美日韩中文二区| 亚洲色偷拍另类无码专区|